News
Suicide rate high in patients with head and neck cancer
- Author:
- Jennifer Shepphird
Key clinical point: Patients with head and neck cancer have a significantly higher suicide rate than the general population. Major finding: The...
News
Survivors of childhood cancers at increased risk for autoimmune diseases
- Author:
- Jennifer Shepphird
Key clinical point: Survivors of childhood cancers, especially leukemia, Hodgkin lymphoma, and renal tumors, had a significantly increased risk of...
News
Higher Risk for Basal Cell Carcinoma Linked to Menopausal Hormone Therapy
- Author:
- Jennifer Shepphird
Key clinical point: Risk of basal cell carcinoma was higher in women with late age of natural menopause and in women who used menopausal hormone...
News
Surgery, dose-escalated chemoradiotherapy yield similar outcomes in NSCLC
- Author:
- Jennifer Shepphird
Key clinical point: After a complex induction protocol, patients with non–small cell lung cancer (NSCLC) who underwent surgery vs. dose-escalated...
News
Adjuvant lapatinib added no benefit against head and neck squamous cell carcinoma
- Author:
- Jennifer Shepphird
Key clinical point: After surgery for high-risk squamous cell carcinoma of the head and neck, the addition of lapatinib to chemoradiotherapy and...
News
Higher risk of basal cell carcinoma linked to menopausal hormone therapy
- Author:
- Jennifer Shepphird
Late age of natural menopause and use of menopausal hormone therapy were associated with significantly increased risk of basal cell carcinoma,...
News
Adjuvant imatinib for 3 years better than 1 year in high-risk GIST
- Author:
- Jennifer Shepphird
Key clinical point: Patients with high-risk GIST treated with adjuvant imatinib for 3 years had longer relapse-free survival (RFS) and overall...
News
Dose-intensive, multiagent regimen improves outcomes from low-risk rhabdomyosarcoma
- Author:
- Jennifer Shepphird
Key clinical point: A dose-intensive, multiagent regimen including dose-compressed cycles of ifosfamide/etoposide and vincristine/doxorubicin/...
News
Intermittent interferon falls short for stage III melanoma patients
- Author:
- Jennifer Shepphird
Key clinical point: Distant metastasis-free survival and overall survival were similar in patients with stage III melanoma treated with...
News
Low BMI predicted worse survival in mCRC
- Author:
- Jennifer Shepphird
Key clinical point: Low BMI predicted worse overall and progression-free survival in patients with mCRC. Major finding: Risks of death and...
News
High-radiation doses improve survival with inoperable intrahepatic cholangiocarcinoma
- Author:
- Jennifer Shepphird
Key clinical point: High-radiation doses delivered to hepatic tumors were well tolerated and survival outcomes were comparable to surgical...
News
Gene mutations had little impact on everolimus benefit in advanced breast cancer
- Author:
- Jennifer Shepphird
Key clinical point: Mutations in genes involved in the PI3K/mTOR pathway, FGFR signaling, and cell cycle regulation had little impact on...
News
Blacks receive inferior care for localized prostate cancer
- Author:
- Jennifer Shepphird
Key clinical point: Compared with whites, black patients with localized prostate cancer received lower quality of care. Major finding: Blacks...
News
Small nucleolar RNA signals colorectal cancer outcomes
- Author:
- Jennifer Shepphird
Expression of small nucleolar RNA SNORA42 was associated with poor overall and disease-free survival in patients with colorectal cancer.
News
Cladribine plus cytarabine yields 85% 5-year survival in Langerhans cell histiocytosis
- Author:
- Jennifer Shepphird
After standard therapy failed, cladribine plus cytarabine was effective in treating patients with high-risk, organ-positive Langerhans cell...